Extended half‐life pegylated, full‐length recombinant factor VIII for prophylaxis in children with severe haemophilia A - Mullins, E. S.; Stasyshyn, O.; Alvarez‐Román, M. T.; Osman, D.; Liesner, R.; Engl, W.; Sharkhawy, M.; Abbuehl, B. E. (Haemophilia : the official journal of the World Federation of Hemophilia, 2017)
Keywords: Antibodies; Bleeding; Child; Child, Preschool; Children; Coagulation factors; extended half‐life FVIII; Factor VIII - therapeutic use; Factor VIII deficiency; Female; Hemophilia; Hemophilia A - drug therapy; Hemophilia A - pathology; Humans; Immunogenicity; Male; Pharmacokinetics; Polyethylene glycol; Prophylaxis; Prospective Studies; Quality of Life; Side effects; children; prophylaxis; extended half-life FVIII